Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-06

Clinical Trial Update: Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a Gonal-F filled-by-mass liquid formulation (follitropin alfa) delivered by a pen for ovulation induction and in vitro fertili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonal-F (follitropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 3 | Status: COMPLETED | Results posted: 2018-04-06